Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017: A SEER Database Analysis

被引:0
|
作者
Zou, Sijue [2 ]
Cui, Liwen [1 ]
Pai, Pearl [1 ]
Lu, Yiping [1 ]
Li, Xiangyang [1 ]
Wang, Gang [1 ]
Huang, Wen [1 ]
Wang, Dan [3 ]
Shaikh, Nikhat [4 ,5 ]
Peng, Zhangzhe [2 ]
Peng, Zhuoming [6 ]
He, Haiyan [1 ]
Liao, Zhouning [1 ]
机构
[1] Univ Hong Kong, Shenzhen Hosp, Dept Nephrol, Shenzhen, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
[4] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Translat Immunol, Hamburg, Germany
[6] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Resp & Intens Care Med, Shenzhen 518000, Guangdong, Peoples R China
来源
JOURNAL OF CANCER | 2025年 / 16卷 / 05期
关键词
SEER; Clear cell renal cell carcinoma; Incidence; Age mortality;
D O I
10.7150/jca.105713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Clear cell renal cell carcinoma (ccRCC) incidence and death have considerably changed in recent years. Our study aimed to investigate the incidence, survival, and tumor characteristics of ccRCC in the year of diagnosis. Methods: Our study participants were selected from the SEER database (2000-2017). Age-standardized incidence rates were calculated to compare incidence rates across time. In addition, we used Kaplan-Meier curves to calculate overall survival (OS) and Cox proportional hazards models to explore risk factors associated with mortality outcomes in patients with ccRCC. Results: In the SEER analysis from 2000 to 2017, the increasing trend in age-adjusted incidence of ccRCC has remained relatively stable over the years, increasing from 2.63 per 100,000 in 2000 to 8.79 per 100,000 in 2017. The increase in the incidence of patients at a localized stage plays a decisive role in the overall increase in the incidence of ccRCC. Conclusions: In the general population, patients diagnosed between 2009-2017 had a higher survival rate than those diagnosed between 2000-2008, which is consistent with all stages of the tumor. The incidence of ccRCC increases steadily with the year of diagnosis, while overall survival has significantly improved.
引用
收藏
页码:1591 / 1597
页数:7
相关论文
共 50 条
  • [41] Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database
    Nie, Duorui
    Yang, Jing
    Zheng, Hao
    Lai, Guihua
    Wang, Fei
    Cao, Jianxiong
    Gong, Chun
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [42] Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database
    Duorui Nie
    Jing Yang
    Hao Zheng
    Guihua Lai
    Fei Wang
    Jianxiong Cao
    Chun Gong
    BMC Gastroenterology, 23
  • [43] Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis
    Jiang, Lai
    Ren, Xing
    Yang, Jinyan
    Chen, Haiqing
    Zhang, Shengke
    Zhou, Xuancheng
    Huang, Jinbang
    Jiang, Chenglu
    Gu, Yuheng
    Tang, Jingyi
    Yang, Guanhu
    Chi, Hao
    Qin, Jianhua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [44] Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
    Tan, Ying
    Li, Bijuan
    Peng, Fang
    Gong, Guanghui
    Li, Ning
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [45] Proteomics Characterization of Clear Cell Renal Cell Carcinoma
    Miranda-Poma, Jesus
    Trilla-Fuertes, Lucia
    Lopez-Vacas, Rocio
    Lopez-Camacho, Elena
    Garcia-Fernandez, Eugenia
    Pertejo, Ana
    Lumbreras-Herrera, Maria, I
    Zapater-Moros, Andrea
    Diaz-Almiron, Mariana
    Dittmann, Antje
    Fresno Vara, Juan Angel
    Espinosa, Enrique
    Gonzalez-Peramato, Pilar
    Pinto-Marin, Alvaro
    Gamez-Pozo, Angelo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [46] TMEM27 expression and clinical characteristics and survival in clear cell renal cell carcinoma
    Grewal, Rickinder
    Choung, Hae Yoon G.
    Roberts, Lisa L.
    Beane, Timothy
    Chen, Luojing
    Gilroy, Daniel X.
    Rappold, Phillip M.
    Le, Thu H.
    ACTA ONCOLOGICA, 2022, 61 (12) : 1507 - 1511
  • [47] Cellular milieu in clear cell renal cell carcinoma
    Raghubar, Arti M. M.
    Roberts, Matthew J. J.
    Wood, Simon
    Healy, Helen G. G.
    Kassianos, Andrew J. J.
    Mallett, Andrew J. J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma
    Fahey, Catherine C.
    Rathmell, W. Kimryn
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (02)
  • [49] Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
    Qiu Zhengqi
    Guo Zezhi
    Jiang Lei
    Qiu He
    Pan Jinyao
    Ao Ying
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)
  • [50] DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
    Evelonn, Emma Andersson
    Landfors, Mattias
    Haider, Zahra
    Kohn, Linda
    Ljungberg, Borje
    Roos, Goran
    Degerman, Sofie
    BMC CANCER, 2019, 19 (1)